Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Yoon, Sang Min ^a   Lim, Young Suk ^a   Park, Mee Jin ^a   Kim, So Yeon ^a   Cho, Byungchul ^a   Shim, Ju Hyun ^a   Kim, Kang Mo ^a   Lee, Han Chu ^a   Chung, Young Hwa ^a   Lee, Yung Sang ^a   Lee, Sung Gyu ^a   Lee, Yu Sun ^a   Park, Jin Hong ^a   Kim, Jong Hoon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CONTROL; CANCER SURVIVAL; CHOLESTASIS; CLINICAL EFFECTIVENESS; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; LIVER TOXICITY; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SAFETY; RADIATION RESPONSE; RIB FRACTURE; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION DOSAGE; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REGISTRIES; RETREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84892532527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079854     Document Type: Article

References (25)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917. doi:10.1002/ijc.25516. PubMed: 21351269.
2. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022. doi:10.1002/hep.24199. PubMed: 21374666.
3. Lau WY, Lai EC (2007) Salvage surgery following downstaging of unresectable hepatocellular carcinoma - a strategy to increase resectability. Ann Surg Oncol 14: 3301-3309. doi:10.1245/s10434-007-9549-7. PubMed: 17891443.
4. Krishnan S, Dawson LA, Seong J, Akine Y, Beddar S et al. (2008) Radiotherapy for hepatocellular carcinoma: an overview. Ann Surg Oncol 15: 1015-1024. doi:10.1245/s10434-007-9729-5. PubMed: 18236114.
5. Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ et al. (2011) Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 81: e447-e453. doi:10.1016/j.ijrobp.2011.04.011. PubMed: 21645977.
6. Kwon JH, Bae SH, Kim JY, Choi BO, Jang HS et al. (2010) Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 10: 475. doi:10.1186/1471-2407-10-475. PubMed: 20813065.
7. Méndez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ et al. (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol 45: 831-837. doi:10.1080/02841860600897934. PubMed: 16982547.
8. Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B et al. (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26: 657-664. doi:10.1200/JCO.2007.14.3529. PubMed: 18172187.
9. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A et al. (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62: 1371-1378. doi: 10.1016/j.ijrobp.2005.01.002. PubMed: 16029795.
10. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK et al. (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76: S94-100. doi:10.1016/j.ijrobp.2009.06.092. PubMed: 20171524.
11. Ishii H, Furuse J, Kinoshita T, Konishi M, Nakagohri T et al. (2008) Hepatectomy for hepatocellular carcinoma patients who meet the Milan criteria. Hepatogastroenterology 55: 621-626. PubMed: 18613420.
12. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328. doi:10.1097/01.sla.0000201480.65519.b8. PubMed: 16495695.
13. Feng K, Yan J, Li X, Xia F, Ma K et al. (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57: 794-802. doi:10.1016/j.jhep.2012. 05.007. PubMed: 22634125.
14. Huang J, Yan L, Cheng Z, Wu H, Du L et al. (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252: 903-912. doi:10.1097/SLA.0b013e3181efc656. PubMed: 21107100.
15. Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52: 762-773. doi:10.1002/hep.23725. PubMed: 20564355.
16. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379: 1245-1255. doi:10.1016/S0140-6736(11)61347-0. PubMed: 22353262.
17. Huang WY, Jen YM, Lee MS, Chang LP, Chen CM et al. (2012) Stereotactic body radiation therapy in recurrent hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 84: 355-361. doi:10.1016/j.ijrobp.2011.11.058. PubMed: 22342300.
18. Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW et al. (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102: 209-214. doi:10.1002/jso.21593. PubMed: 20740576.
19. Taguchi H, Sakuhara Y, Hige S, Kitamura K, Osaka Y et al. (2007) Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresec table with other modalities. Int J Radiat Oncol Biol Phys 69: 376-380. doi:10.1016/j. ijrobp.2007.07.1483. PubMed: 17869660.
20. Livraghi T, Lazzaroni S, Meloni F (2001) Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 13: 159-166. doi:10.1016/S0929- 8266(01)00128-8. PubMed: 11369527.
21. Sala M, Llovet JM, Vilana R, Bianchi L, Solé M et al. (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40: 1352-1360. doi:10.1002/hep.20465. PubMed: 15565564.
22. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO et al. (2005) Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11: 1086-1092. doi:10.1002/lt.20472. PubMed: 16123959.
23. Yang W, Chen MH, Yin SS, Yan K, Gao W et al. (2006) Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. AJR Am J Roentgenol 186: S275-S283. doi:10.2214/AJR.04.1573. PubMed: 16632688.
24. Bae SH, Park HC, Lim do H, Lee JA, Gwak GY et al. (2012) Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 82: e603-e607. doi:10.1016/j.ijrobp.2011.09.053. PubMed: 22208963.
25. Cárdenes HR, Price TR, Perkins SM, Maluccio M, Kwo P et al. (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12: 218-225. doi:10.1007/s12094-010- 0492-x. PubMed: 20231127.